Loïck Galland

Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study

Xavier Deschênes‐Simard, Corentin Richard, Loïck Galland et al. · Thrombosis Research · 2021 · 52 citations

Thrombosis, Venous Disease, Venous Thrombosis +11

Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides

Erik N. Bergstrom, Ammal Abbasi, Marcos Díaz‐Gay et al. · Journal of Clinical Oncology · 2024 · 51 citations · Full text

Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

R. Descourt, M. Pérol, G. Rousseau-Bussac et al. · Lung Cancer · 2019 · 28 citations · Full text

Medicine, Metronomic Therapy, Pathology +9

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer

Loïck Galland, Julie Lecuelle, Laure Favier et al. · Cancers · 2021 · 27 citations · Full text

Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1

Loïck Galland, Anne Laure Le Page, Julie Lecuelle et al. · OncoImmunology · 2021 · 27 citations · Full text

Lung Adenocarcinoma, Immunology, Pathology +16